Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sotiris Loizidis
Observed name:
S. Loizidis
Institution:
Bank of Cyprus Oncology Center
Observed institution:
Bank of Cyprus Oncology Center
ORCID:
0000-0002-9875-7479
Observed ORCID:
0000-0002-9875-7479
OpenAlex ID:
A5118825195
Liquid biopsy in breast cancer: promises and challenges
2025
·
Sotiris Loizidis
, Maria-Alexandra Stanciu
, et al.
·
Current Opinion in Oncology
·
13
Docetaxel and Ramucirumab as Subsequent Treatment After First-Line Immunotherapy-Based Treatment for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Study and Literature Review
2025
·
Sotiris Loizidis
, Paris Vogazianos
, et al.
·
Current Oncology
·
3
PDF
Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study
2026
·
Sotiris Loizidis
, Damianos Michaelides
, et al.
·
Cancers
·
1
PDF
153eP First-line immuno-oncology treatment patterns in metastatic non-small cell lung cancer in Cyprus
2026
·
H.C. Charalambous
, S. Loizidis
, et al.
·
ESMO Open
Alpelisib Plus Endocrine Therapy Versus Everolimus Plus Endocrine Therapy After Cdk4/6 Inhibitor Failure in Pik3ca-mutant Advanced Breast Cancer
2025
·
Sotiris Loizidis
, Myria Galazi
, et al.
·
The Breast
Metastatic Pheochromocytoma in a Patient With Li-Fraumeni Syndrome
2025
·
Sotiris Loizidis
, Christiana Matthaiou
, et al.
·
JCEM Case Reports
PDF
Show more works
View as search
Works count:
6
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type